annual FCF:
-$363.61M+$7.32M(+1.97%)Summary
- As of today (June 17, 2025), DNLI annual free cash flow is -$363.61 million, with the most recent change of +$7.32 million (+1.97%) on December 31, 2024.
- During the last 3 years, DNLI annual FCF has fallen by -$143.72 million (-65.36%).
- DNLI annual FCF is now -188.03% below its all-time high of $413.06 million, reached on December 31, 2020.
Performance
DNLI Free cash flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly FCF:
-$136.55M-$47.74M(-53.76%)Summary
- As of today (June 17, 2025), DNLI quarterly free cash flow is -$136.55 million, with the most recent change of -$47.74 million (-53.76%) on March 31, 2025.
- Over the past year, DNLI quarterly FCF has dropped by -$20.78 million (-17.95%).
- DNLI quarterly FCF is now -126.63% below its all-time high of $512.72 million, reached on December 31, 2020.
Performance
DNLI quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM FCF:
-$384.38M-$20.78M(-5.71%)Summary
- As of today (June 17, 2025), DNLI TTM free cash flow is -$384.38 million, with the most recent change of -$20.78 million (-5.71%) on March 31, 2025.
- Over the past year, DNLI TTM FCF has increased by +$40.73 million (+9.58%).
- DNLI TTM FCF is now -192.54% below its all-time high of $415.39 million, reached on March 31, 2021.
Performance
DNLI TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Free cash flow Formula
FCF = Cash From Operations − CAPEX
DNLI Free cash flow Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | +2.0% | -17.9% | +9.6% |
3 y3 years | -65.4% | -79.3% | -58.2% |
5 y5 years | -114.5% | -146.6% | -99.7% |
DNLI Free cash flow Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | -65.4% | +2.0% | -198.2% | at low | -64.4% | +9.6% |
5 y | 5-year | -188.0% | +2.0% | -126.6% | at low | -192.5% | +9.6% |
alltime | all time | -188.0% | +2.0% | -126.6% | at low | -192.5% | +9.6% |
DNLI Free cash flow History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Mar 2025 | - | -$136.55M(+53.8%) | -$384.38M(+5.7%) |
Dec 2024 | -$363.61M(-2.0%) | -$88.81M(+40.9%) | -$363.61M(-3.2%) |
Sep 2024 | - | -$63.02M(-34.4%) | -$375.69M(-6.6%) |
Jun 2024 | - | -$96.01M(-17.1%) | -$402.10M(-5.4%) |
Mar 2024 | - | -$115.77M(+14.7%) | -$425.11M(+14.6%) |
Dec 2023 | -$370.93M(+41.3%) | -$100.89M(+12.8%) | -$370.93M(+6.7%) |
Sep 2023 | - | -$89.43M(-24.9%) | -$347.55M(+8.2%) |
Jun 2023 | - | -$119.02M(+93.3%) | -$321.21M(+29.5%) |
Mar 2023 | - | -$61.59M(-20.5%) | -$247.99M(-5.5%) |
Dec 2022 | -$262.55M(+19.4%) | -$77.51M(+22.8%) | -$262.55M(+3.5%) |
Sep 2022 | - | -$63.10M(+37.8%) | -$253.58M(+8.5%) |
Jun 2022 | - | -$45.79M(-39.9%) | -$233.80M(-3.8%) |
Mar 2022 | - | -$76.15M(+11.1%) | -$243.00M(+10.5%) |
Dec 2021 | -$219.89M(-153.2%) | -$68.55M(+58.3%) | -$219.89M(-160.8%) |
Sep 2021 | - | -$43.31M(-21.2%) | $361.38M(-10.6%) |
Jun 2021 | - | -$54.99M(+3.7%) | $404.07M(-2.7%) |
Mar 2021 | - | -$53.04M(-110.3%) | $415.39M(+0.6%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Dec 2020 | $413.06M(-343.7%) | $512.72M(<-9900.0%) | $413.06M(-375.2%) |
Sep 2020 | - | -$620.00K(-98.6%) | -$150.08M(-17.9%) |
Jun 2020 | - | -$43.67M(-21.1%) | -$182.74M(-5.1%) |
Mar 2020 | - | -$55.37M(+9.8%) | -$192.51M(+13.6%) |
Dec 2019 | -$169.50M(-462.8%) | -$50.42M(+51.5%) | -$169.50M(+520.2%) |
Sep 2019 | - | -$33.28M(-37.7%) | -$27.33M(-8.0%) |
Jun 2019 | - | -$53.45M(+65.2%) | -$29.72M(+59.2%) |
Mar 2019 | - | -$32.35M(-135.3%) | -$18.67M(-140.0%) |
Dec 2018 | $46.72M(-158.8%) | $91.75M(-357.2%) | $46.72M(-172.5%) |
Sep 2018 | - | -$35.67M(-15.9%) | -$64.43M(+26.2%) |
Jun 2018 | - | -$42.40M(-228.3%) | -$51.05M(+90.5%) |
Mar 2018 | - | $33.04M(-270.2%) | -$26.79M(-66.3%) |
Dec 2017 | -$79.51M(+1.9%) | -$19.41M(-12.9%) | -$79.51M(+32.3%) |
Sep 2017 | - | -$22.29M(+22.9%) | -$60.10M(+58.9%) |
Jun 2017 | - | -$18.14M(-7.8%) | -$37.81M(+92.2%) |
Mar 2017 | - | -$19.68M | -$19.68M |
Dec 2016 | -$78.04M(+330.8%) | - | - |
Dec 2015 | -$18.11M | - | - |
FAQ
- What is Denali Therapeutics annual free cash flow?
- What is the all time high annual FCF for Denali Therapeutics?
- What is Denali Therapeutics annual FCF year-on-year change?
- What is Denali Therapeutics quarterly free cash flow?
- What is the all time high quarterly FCF for Denali Therapeutics?
- What is Denali Therapeutics quarterly FCF year-on-year change?
- What is Denali Therapeutics TTM free cash flow?
- What is the all time high TTM FCF for Denali Therapeutics?
- What is Denali Therapeutics TTM FCF year-on-year change?
What is Denali Therapeutics annual free cash flow?
The current annual FCF of DNLI is -$363.61M
What is the all time high annual FCF for Denali Therapeutics?
Denali Therapeutics all-time high annual free cash flow is $413.06M
What is Denali Therapeutics annual FCF year-on-year change?
Over the past year, DNLI annual free cash flow has changed by +$7.32M (+1.97%)
What is Denali Therapeutics quarterly free cash flow?
The current quarterly FCF of DNLI is -$136.55M
What is the all time high quarterly FCF for Denali Therapeutics?
Denali Therapeutics all-time high quarterly free cash flow is $512.72M
What is Denali Therapeutics quarterly FCF year-on-year change?
Over the past year, DNLI quarterly free cash flow has changed by -$20.78M (-17.95%)
What is Denali Therapeutics TTM free cash flow?
The current TTM FCF of DNLI is -$384.38M
What is the all time high TTM FCF for Denali Therapeutics?
Denali Therapeutics all-time high TTM free cash flow is $415.39M
What is Denali Therapeutics TTM FCF year-on-year change?
Over the past year, DNLI TTM free cash flow has changed by +$40.73M (+9.58%)